PGP and colorectal carcinoma: Since the expression of the multidrug transporter P-gp was found to be NF-kB-dependent it is conceivable that the co-administration of chemotherapeutic agents and NF-κB inhibitors could decrease P-gp expression and restore chemosensitivity in CRC cells.